KORU Medical Systems Inc. (KRMD) is a Medical/Dental Instruments company listed on NASDAQ. In the last 30 days Quantisnow tracked 2 wire items for KRMD, including 1 earnings update and 1 press release or news item. The most recent was published Nov 4, 2026.
KRMD rankings
Financial highlights
Full financials- Revenue, TTM
- $45.11M
- Revenue growth
- +22.4%
- Net income, TTM
- -$1.82M
- Net margin
- -4.0%
- Free cash flow, TTM
- $776.7K
- Cash
- $8.29M
For the twelve months ended Jun 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks35-67%
2026-05-102026-11-01
Mix990d
- Insider7(78%)
- Earnings1(11%)
- Other1(11%)
Latest news
25 items- PRKORU Medical Systems to Participate in Upcoming Investor ConferencesKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will participate in the following investor conference: Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum. Management is scheduled to present on November 11th, 2026 at 8:30 am ET. Interested parties can access the live and archived webcast on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. Craig Hallum Alpha Select. Management will
- PRKORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report third quarter 2026 financial results on Tuesday, November 10, 2026. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Conference Call and Webcast Details The conference call can be accessed by dialing (877)-407-0784 for participants in the U.S. or Canada and (201)-689-8560 for internationa
- INSIDERDirector Manko Joseph M. Jr. was granted 5,119 shares (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERDirector Wholihan Edward was granted 5,119 shares, increasing direct ownership by 10% to 56,431 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERDirector French Donna was granted 5,119 shares, increasing direct ownership by 5% to 103,633 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERDirector Cascella Robert was granted 5,119 shares, increasing direct ownership by 5% to 103,274 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERChairman of the Board Fletcher R John was granted 7,679 shares, increasing direct ownership by 3% to 239,836 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERDirector Matin Shahriar was granted 5,119 shares, increasing direct ownership by 5% to 106,263 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERChief Commercial Officer Kalbermatten Adam R bought $101,120 worth of shares (32,000 units at $3.16), increasing direct ownership by 9% to 394,017 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERChief Commercial Officer Kalbermatten Adam R converted options into 75,000 shares and covered exercise/tax liability with 25,483 shares, increasing direct ownership by 16% to 362,017 units (SEC Form 4) to satisfy withholding obligation4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- SECSEC Form 10-Q filed by KORU Medical Systems Inc.10-Q - KORU Medical Systems, Inc. (0000704440) (Filer)
- SECKORU Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - KORU Medical Systems, Inc. (0000704440) (Filer)
- PRKORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 GuidanceKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2026. The Company also updated guidance for the full year 2026. Second Quarter 2026 and Recent Highlights Net revenues grew 18% over the prior year period to $12.0 million Gross profit grew 20% over the prior year period to $7.8 million, with gross margin of 65.1% Net income improved 222% over the prior year period to $0.25 million Acquired a connecte
- PRKORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth ConferenceKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will participate in the Canaccord Genuity 46th Annual Growth Conference on August 12th, 2026. KORU Medical's management is scheduled to present at the Canaccord Genuity 46th Annual Growth Conference on August 12th, 2026, at 10:00 am ET. Interested parties can access the live and archived webcast on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. About KORU M
- PRKORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report second quarter 2026 financial results on Wednesday, August 5, 2026. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Conference Call and Webcast Details The conference call can be accessed by dialing (877)-407-0784 for participants in the U.S. or Canada and (201)-689-8560 for internationa
- INSIDERAmendment: SEC Form 4 filed by President and CEO Kalbermatten Adam R4/A - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERSEC Form 4 filed by President and CEO Kalbermatten Adam R4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERDirector Wholihan Edward was granted 3,571 shares, increasing direct ownership by 7% to 51,312 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERDirector Matin Shahriar was granted 3,571 shares, increasing direct ownership by 4% to 101,144 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERDirector French Donna was granted 3,571 shares, increasing direct ownership by 4% to 98,514 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERChairman of the Board Fletcher R John was granted 5,357 shares, increasing direct ownership by 2% to 232,157 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERDirector Cascella Robert was granted 3,571 shares, increasing direct ownership by 4% to 98,155 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERDirector Manko Joseph M. Jr. was granted 3,571 shares (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- SECKORU Medical Systems Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - KORU Medical Systems, Inc. (0000704440) (Filer)
- INSIDERPresident-Chief Commercial Off Kalbermatten Adam R bought $19,800 worth of shares (5,000 units at $3.96) and bought $29,475 worth of Common Stick (7,500 units at $3.93), increasing direct ownership by 4% to 312,500 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
KRMD FAQ
10 questionsWhat does KORU Medical Systems Inc. do?
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales...What is the latest news on KRMD?
In the last 30 days Quantisnow tracked 2 wire items for KRMD: 1 earnings update and 1 press release or news item. The most recent was published on November 4, 2026.What is KRMD revenue?
KORU Medical Systems Inc. (KRMD) reported $45.11M of revenue for the twelve months ended Jun 30, 2026. That is up 22.4% from the year before. Revenue for fiscal 2025 was $41.13M.Is KRMD profitable?
No. KORU Medical Systems Inc. reported a net loss of $1.82M for the twelve months ended Jun 30, 2026.How much cash and debt does KRMD have?
KORU Medical Systems Inc. reported $8.29M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does KRMD stock trade?
KORU Medical Systems Inc. (KRMD) is listed on NASDAQ.What sector and industry is KRMD in?
KORU Medical Systems Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about KRMD?
Across the last 6 analyst actions on KORU Medical Systems Inc., there were 2 upgrades and 1 downgrade. The most recent action was from Piper Sandler: Neutral with a $4.50 price target on 2025-02-14. Recent price targets range from $3.50 to $4.50.What companies are similar to KRMD?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare KRMD side-by-side with any of them on Quantisnow.How can I track KRMD on Quantisnow?
Quantisnow aggregates KORU Medical Systems Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow KRMD to receive live email and push alerts on every new disclosure.